Ramy A. Fayad, M.D.December 18, 2024

FDA 483 - Ramy A. Fayad, M.D. - December 18, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ramy A. Fayad, M.D.

Record Details

An FDA inspection of Ramy A. Fayad, M.D. in Toledo, OH, identified a significant issue regarding the timely reporting of serious adverse events. The clinical investigator failed to adhere to protocol requirements for reporting an SAE, specifically a subject's hospitalization for pneumonia, within the specified timeframe. This indicates a lapse in adherence to clinical trial protocols for patient safety reporting.

Company: Ramy A. Fayad, M.D.
Inspection Date: December 18, 2024
Product Type: Other
Office: Cincinnati District Office
Person: Brittany M. Kershaw

Open in Dashboard

ID · a64c6380-54a7-44bb-a07e-1a1900a638fd